Search results
- 1.0572137 - BTÚ 2024 RIV US eng J - Journal Article
Morath, V. - Brandt, C. - Deuschle, F. - Mendler, C. T. - Blechert, B. - Summer, D. - Bařinka, Cyril - Decristoforo, C. - Weber, W. A. - Schwaiger, M. - Skerra, A.
Molecular Design of 68Ga-and 89Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors.
Molecular Pharmaceutics. Roč. 20, č. 5 (2023), s. 2490-2501. ISSN 1543-8384. E-ISSN 1543-8392
R&D Projects: GA MŠMT LX22NPO5102
Institutional support: RVO:86652036
Keywords : N-acetyl-L-aspartyl-L-glutamate dipeptidase I * folate hydrolase 1 * gcpii * gcpiii
OECD category: Pharmacology and pharmacy
Impact factor: 4.9, year: 2022
Method of publishing: Limited access
https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.2c01066
Permanent Link: https://hdl.handle.net/11104/0343332 - 2.0559889 - ÚOCHB 2023 RIV eng P - Patent Document
Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
2022. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 10.05.2022. Patent Number: US11325931
Institutional support: RVO:61388963
Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/055264571/publication/US11325931B2?q=US11325931B2
Permanent Link: https://hdl.handle.net/11104/0333018 - 3.0559886 - ÚOCHB 2023 RIV eng P - Patent Document
Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
2022. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 12.01.2022. Patent Number: EP3177632
Institutional support: RVO:61388963
Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/055264571/publication/EP3177632B1?q=EP3177632B1
Permanent Link: https://hdl.handle.net/11104/0333015 - 4.0558031 - ÚOCHB 2023 RIV CH eng J - Journal Article
Krečmerová, Marcela - Majer, Pavel - Rais, R. - Slusher, B. S.
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.
Frontiers in Chemistry. Roč. 10, May (2022), č. článku 889737. ISSN 2296-2646. E-ISSN 2296-2646
R&D Projects: GA MŠMT(CZ) LM2018133
Institutional support: RVO:61388963
Keywords : acyclic nucleoside phosphonates * antivirals * prodrugs * protides * GCPII * prostate-specific membrane antigen * FOLH1 * 2-PMPA
OECD category: Organic chemistry
Impact factor: 5.5, year: 2022
Method of publishing: Open access
https://doi.org/10.3389/fchem.2022.889737
Permanent Link: http://hdl.handle.net/11104/0331849 - 5.0544774 - ÚOCHB 2022 RIV eng P - Patent Document
Slusher, B. S. - Rais, R. - Vávra, Jan - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej - Tenora, Lukáš
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors.
2021. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 13.07.2021. Patent Number: US11059775
Institutional support: RVO:61388963
Keywords : hydroxamate * prodrugs * GCPII inhibitors
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0321584 - 6.0531699 - ÚOCHB 2021 RIV eng P - Patent Document
Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
2020. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 28.01.2020. Patent Number: US10544176
Institutional support: RVO:61388963
Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=10544176B2&KC=B2&FT=D&ND=4&date=20200128&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0310314 - 7.0510216 - ÚOCHB 2020 RIV US eng J - Journal Article
Vorlová, Barbora - Knedlík, Tomáš - Tykvart, Jan - Konvalinka, Jan
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.
Frontiers in Bioscience. Roč. 24, č. 4 (2019), s. 648-687. ISSN 1093-9946. E-ISSN 1093-4715
R&D Projects: GA MŠMT LO1302
Institutional support: RVO:61388963
Keywords : GCPII * GCPIII * PSMA * FOLH1 * NAALAD2 * NAAG * folate * BCG * Review
OECD category: Biochemistry and molecular biology
Impact factor: 2.747, year: 2019
Method of publishing: Limited access
http://www.bioscience.org/2019/v24/af/4742/list.htm
Permanent Link: http://hdl.handle.net/11104/0300749 - 8.0501191 - ÚOCHB 2019 RIV eng P - Patent Document
Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
2018. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 05.06.2018. Patent Number: US9988407
Institutional support: RVO:61388963
Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9988407B2&KC=B2&FT=D&ND=4&date=20180605&DB=&locale=en_EP#
Permanent Link: http://hdl.handle.net/11104/0293187File Download Size Commentary Version Access 0501191.pdf 7 5.3 MB Other open-access - 9.0492895 - ÚOCHB 2019 RIV US eng J - Journal Article
Neburková, Jitka - Sedlák, František - Žáčková Suchanová, J. - Kostka, Libor - Šácha, Pavel - Šubr, Vladimír - Etrych, Tomáš - Šimon, Petr - Bařinková, Jitka - Kryštůfek, Robin - Španielová, Hana - Forstová, J. - Konvalinka, Jan - Cígler, Petr
Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.
Molecular Pharmaceutics. Roč. 15, č. 8 (2018), s. 2932-2945. ISSN 1543-8384. E-ISSN 1543-8392
R&D Projects: GA ČR(CZ) GA16-16336S; GA ČR(CZ) GA16-02938S; GA MŠMT LO1302
Institutional support: RVO:61388963 ; RVO:61389013
Keywords : GCPII * PSMA * inhibitor * click chemistry * targeting * cell * nanodiamond
OECD category: Biochemistry and molecular biology; Polymer science (UMCH-V)
Impact factor: 4.396, year: 2018
Permanent Link: http://hdl.handle.net/11104/0286398 - 10.0492495 - ÚOCHB 2019 RIV NL eng J - Journal Article
Chaloupková, Z. - Balzerová, A. - Bařinková, J. - Medříková, Z. - Šácha, Pavel - Beneš, P. - Ranc, V. - Konvalinka, J. - Zbořil, R.
Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Analytica Chimica Acta. Roč. 997, Jan 2 (2018), s. 44-51. ISSN 0003-2670. E-ISSN 1873-4324
R&D Projects: GA MŠMT LO1302; GA MŠMT(CZ) LO1304; GA ČR(CZ) GA16-02938S
Institutional support: RVO:61388963
Keywords : Raman spectroscopy * nanocomposites * prostate cancer * GCPII * MA-SERS
OECD category: Biochemistry and molecular biology
Impact factor: 5.256, year: 2018
Permanent Link: http://hdl.handle.net/11104/0286008